| Project/Area Number |
16390027
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | RIKEN |
|---|
Principal Investigator |
ADACHI Hideki Riken, Cellular Biochemistry Laboratory, Researcher, 辻本細胞生化学研究室, 先任研究員 (60291051)
|
|---|
| Project Period (FY) |
2004 – 2005
|
| Project Status |
Completed (Fiscal Year 2005)
|
| Budget Amount *help |
¥6,700,000 (Direct Cost: ¥6,700,000)
Fiscal Year 2005: ¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2004: ¥3,700,000 (Direct Cost: ¥3,700,000)
|
|---|
| Keywords | FEEL / arteriosclerosis / diabetes / スカベンジャー受容体 / 血管内皮細胞 / ノックアウトマウス |
|---|
| Research Abstract |
Multiligand receptors (scavenger receptors) are defined as its ability to recognize several structurally and functionally dissimilar molecule such as modified lipoproteins, advanced glycation end-products (AGE) and apoptotic cells. It is suggested that they were implicated in various diseases such as arteriosclerosis and diabetes. Employing expression cloning, we have cloned a multiligand receptor termed FEEL-1 (fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor-1) expressed in human endothelial cells and subsequently cloned FEEL-2 by data base search. The receptors had binding activities to modified lipoproteins, cells of both Gram-positive, Gram-negative bacteria and AGE. Soluble form of human FEEL-1 was expressed using adenoviral vector, and the binding activities of soluble form of FEEL-1 to acetyl-LDL or AGE were determined. Expression of miRNA (micro RNA) against FEEL employing fiber mutant adenoviral vector in murine liver sinusoidal endothelial cells suggested that both FEEL-1 and FEEL-2 contribute to the hepatic reticuloendothelial system in clearance of waste materials from blood flow. Knockout mice of FEEL-1 or FEEL-2 were generated by gene targeting. Determination of the physiological function of FEEL will provide a new insight into the pathological function of this multiligand receptor.
|
